Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000218687 | SCV000277870 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000939327 | SCV001085169 | likely benign | PTEN hamartoma tumor syndrome | 2024-06-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001731451 | SCV001983453 | likely benign | not specified | 2021-09-20 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000939327 | SCV004825990 | likely benign | PTEN hamartoma tumor syndrome | 2024-06-09 | criteria provided, single submitter | clinical testing |